| Ytd | -47.30% | |
| 1y | -76.21% |
| Open | 0.73 | Prev Close | 0.71 | Low | 0.73 | High | 0.80 | Mkt Cap | 37.86M |
| Vol | 62.97K | Avg Vol | 61.46K | EPS | -0.37 | P/E | N/A | Forward P/E | -7.53 |
| Beta | 0.74 | Short Ratio | 0.19 | Inst. Own | 7.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.00 | 200-d Avg | 1.10 | 1yr Est | 21.65 |
GNTA News
Gainers Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 14.1% to $4.68 during Wednesday
The Spring Assembly manufactured by Sòphia HT, a strategic Genenta investment, supports the separati
MILAN and NAPLES, Italy, July 23, 2026 (GLOBE NEWSWIRE) -- Sòphia High Tech S.r.l. (Sòphia HT), an I
Fiscal Year 2025 Highlights FY2025 sales rose 29.3% to €7.17 million; total value of production incr
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce
Genenta signs Definitive Agreements with Sophia High Tech Genenta enters aerospace as it continues i
MILAN, March 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saent
Focused on selective acquisitions of high-quality companies in strategic industrial sectors Focused
MILAN, March 13, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saen
MILAN, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) in transformation to
Building on Biotech Heritage, Expanding into Defense and National Security Through Industrial Integr
MILAN and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a clinical-sta
Genenta Science S.p.A. Unsponsored ADR (NASDAQ: GNTA - Get Free Report)'s share price rose 0.7% duri
MILAN, Italy and NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a clini
Genenta Science S.p.A. Unsponsored ADR (NASDAQ: GNTA - Get Free Report)'s share price was down 3.4%
Genenta Science S.p.A. initiating with a Buy rating following a 90% stock surge after announcing a s
MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in i
MILAN, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer Company in immuno
MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in i
Milan, Italy and New York, New York--(Newsfile Corp. - May 8, 2025) - Genenta Science, SpA (NASDAQ:
MILAN and NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in im